ΕΛ.Ι.Ε.Κ.

Δημοσιεύσεις 2014

A STUDY OF GENE EXPRESSION MARKERS FOR PREDICTIVE SIGNIFICANCE FOR BEVACIZUMAB BENEFIT IN PATIENTS WITH METASTATIC COLON CANCER: A TRANSLATIONAL RESEARCH STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HeCOG)

G. Pentheroudakis, V. Kotoula, E. Fountzilas, G. Kouvatseas, G. Basdanis, I. Xanthakis, T. Makatsoris, E. Charalambous, PD. apamichael, E. Samantas, P. Papakostas, D. Bafaloukos, E. Razis, C. Christodoulou, I. Varthalitis, N. Pavlidis, G. Fountzilas

BMC Cancer. 2014 Feb 20;14(1):111. doi: 10.1186/1471-2407-14-111

PROGNOSTIC SIGNIFICANCE OF THE WNT PATHWAY IN SQUAMOUS CELL LARYNGEAL CANCER

A. Psyrri, V. Kotoula, E. Fountzilas, Z. Alexopoulou, M. Bobos , D. Televantou, G. Karayannopoulou, D. Krikelis, K. Markou, I. Karasmanis, N. Angouridakis, KT. Kalogeras, A. Nikolaou, G. Fountzilas

Oral Oncol. 2014 Apr;50(4):298-305. doi: 10.1016/j.oraloncology.2014.01.005.

EGFR GENE GAIN AND PTEN PROTEIN EXPRESSION ARE FAVORABLE PROGNOSTIC FACTORS IN PATIENTS WITH KRAS WILD-TYPE METASTATIC COLORECTAL CANCER TREATED WITH CETUXIMAB

E. Razis, G. Pentheroudakis, G. Rigakos, M. Bobos, G. Kouvatseas, O. Tzaida, T. Makatsoris, P. Papakostas, M. Bai, A. Goussia, E. Samantas, D. Papamichael, O. Romanidou, I. Efstratiou, E. Tsolaki, A. Psyrri, W. De Roock, D. Bafaloukos, G. Klouvas, S. Tejpar, KT. Kalogeras, D. Pectasides, G. Fountzilas

J Cancer Res Clin Oncol. 2014 May;140(5):737-48. doi: 10.1007/s00432-014-1626-2.

DIFFERENTIAL EXPRESSION OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR AMONG EARLY BREAST CANCER SUBTYPES

G. Mountzios, D. Aivazi, I. Kostopoulos, HP. Kourea, G. Kouvatseas, E. Timotheadou, P. Zebekakis, I. Efstratiou, H. Gogas, C. Vamvouka, S. Chrisafi, A. Stofas, G. Pentheroudakis, A. Koutras, E. Galani, D. Bafaloukos, G. Fountzilas

PLoS One. 2014 Mar 17;9(3):e91407. doi: 10.1371/journal.pone.0091407.

ASSOCIATION OF VEGF-A SPLICE VARIANT mRNA EXPRESSION WITH OUTCOME IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC BREAST CANCER

G. Pentheroudakis, V. Kotoula, G. Kouvatseas, E. Charalambous, D. Dionysopoulos, F. Zagouri, A. Koutras, K. Papazisis, D. Pectasides, E. Samantas, MA. Dimopoulos, CN. Papandreou, G. Fountzilas

Clin Breast Cancer. 2014 Mar 1. pii: 1526-8209(14)00034-2. doi: 10.1016/j.clbc.2014.02.009.

LACK OF ASSOCIATION BETWEEN KRAS MUTATIONS AND 18F-FDG PET/CT IN CAUCASIAN METASTATIC COLORECTAL CANCER PATIENTS

D. Krikelis, E. Skoura, V. Kotoula, P. Rondogianni, N. Pianou, A. Samartzis, I. Xanthakis, G. Fountzilas, IE. Datseris

Anticancer Res. 2014 May;34(5):2571-9

THE ANDROGEN RECEPTOR AS A SURROGATE MARKER FOR MOLECULAR APOCRINE BREAST CANCER SUBTYPING

S. Lakis, V. Kotoula, AG. Eleftheraki, A. Batistatou, M. Bobos, T. Koletsa, E. Timotheadou, S. Chrisafi, G. Pentheroudakis, A. Koutras, F. Zagouri, H. Linardou, G. Fountzilas

Breast. 2014 Jun;23(3):234-43. doi: 10.1016/j.breast.2014.02.013.

p85 PROTEIN EXPRESSION IS ASSOCIATED WITH POOR SURVIVAL IN HER2-POSITIVE PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH TRASTUZUMAB

K. Pavlakis, M. Bobos, A. Batistatou, V. Kotoula, AG. Eleftheraki, A. Stofas, E. Timotheadou, G. Pentheroudakis, A. Psyrri, A. Koutras, D. Pectasides, P. Papakostas, E. Razis, C. Christodoulou, KT. Kalogeras, G. Fountzilas

Pathol Oncol Res. 2014 Aug 8.

PROGNOSTIC AND PREDICTIVE VALUE OF p-Akt, EGFR, AND p-mTOR IN EARLY BREAST CANCER

G. Lazaridis, S. Lambaki, G. Karayannopoulou, AG. Eleftheraki, I. Papaspirou, M. Bobos, I. Efstratiou, G. Pentheroudakis, N. Zamboglou, G. Fountzilas

Strahlenther Onkol. 2014 Jul;190(7):636-8, 640-5

ADJUSTING BREAST CANCER PATIENT PROGNOSIS WITH NON-HER2-GENE PATTERNS ON CHROMOSOME 17

V. Kotoula, M. Bobos, Z. Alexopoulou, C. Papadimitriou, K. Papadopoulou, E. Charalambous, E. Tsolaki, G. Xepapadakis, I. Nicolaou, I. Papaspirou, G. Aravantinos, C. Christodoulou, I. Efstratiou, H. Gogas, G. Fountzilas

PLoS One. 2014 Aug 6;9(8):e103707. doi: 10.1371/journal.pone.0103707.

alphaB-CRYSTALLIN IS A MARKER OF AGGRESSIVE BREAST CANCER BEHAVIOR BUT DOES NOT INDEPENDENTLY PREDICT FOR PATIENT OUTCOME: A COMBINED ANALYSIS OF TWO RANDOMIZED STUDIES

T. Koletsa, F. Stavridi, M. Bobos, I. Kostopoulos, V. Kotoula, A.G. Eleftheraki, I.Konstantopoulou, Ch. Papadimitriou, A. Batistatou, H. Gogas, A. Koutras, D.V. Skarlos, G. Pentheroudakis, I. Efstratiou, D. Pectasides, G. Fountzilas

BMC Clin Pathol. 2014 Jun 23;14:28. doi: 10.1186/1472-6890-14-28.

A STUDY OF GENE EXPRESSION MARKERS FOR PREDICTIVE SIGNIFICANCE FOR BEVACIZUMAB BENEFIT IN PATIENTS WITH METASTATIC COLON CANCER: A TRANSLATIONAL RESEARCH STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG)

G. Pentheroudakis, V. Kotoula, E. Fountzilas, G.Kouvatseas, G. Basdanis, I. Xanthakis, Th. Makatsoris, E. Charalambous, D. Papamichael, E. Samantas, P. Papakostas, D. Bafaloukos, E. Razis, Ch. Christodoulou, I. Varthalitis, N. Pavlidis and G. Fountzilas

BMC Cancer. 2014 Feb 20;14:111. doi: 10.1186/1471-2407-14-111.

PROGNOSTIC MARKERS IN EARLY STAGE COLORECTAL CANCER: SIGNIFICANCE OF TYMS rnRNA EXPRESSION

A. Koumarianou, I. Tzeveleki, D. Mekras, A.G. Eleftheraki, M. Bobos, R. Wirtz, E. Fountzilas, Ch. Valavanis, I. Xanthakis, K.T. Kalogeras, G. Basdanis, G. Pentheroudakis, V. Kotoula, G. Fountzilas

Anticancer Research, 2014 Sep;34(9):4949-62.

PROTEIN AND MRNA EXPRESSION OF NOTCH PATHWAY COMPONENTS IN OPERABLE TUMORS OF PATIENTS WITH LARYNGEAL CANCER

D. Krikelis, V. Kotoula, M. Bobos, E. Fountzilas, K. Markou, I. Karasmanis, N. Angouridakis, K. Vlachtsis, K.T Kalogeras, A. Nikolaou, G. Fountzilas

Anticancer Res. 2014 Nov;34(11):6495-503